969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

Current Study Opportunities at The CRC

Studies at CRC can change frequently.  For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 1-14-21.

Study #1 : An investigational research study of a once daily investigational tablet versus placebo for people with chronic, unexplained cough (at least 10 times in one hour)

Brief description of study

This investigational research study has 8 visits. Visits will be 2-3 hours each. Appointments may be made Monday through Saturday mornings. Patients must be relatively healthy other than unexplained chronic cough (at least 10 times in an hour). Must not have chronic bronchitis, COPD or uncontrolled asthma. Patient must be non smoker with little to no previous smoke histroy.

Pleae fill out Volunteer Questionnaire or contact Monica Shutz at 314-514-8509 ext 12

Clinical Study Identifier: TX228637

Study #2 : An asthma research study assessing safety and efficacy of an inhaled once daily medication when added to patients already using maintenance inhalers. All subjects are switched to Advair 250 or 500 during the trial.

Brief description of study

This study has 11-12 visits and can be completed in 7 months. Subjects must be using maintenance inhalers and have had an asthma flare requiring Prednsione within the last 12 months. 

Detailed Study Description

Visits must be done in the mornings and we are scheduling subjects Monday-Saturday. Patients must be between 18-75 years of age and currently treating asthma with certain inhaled imedications. Compensation for participation is available to those who qualify.

Please contact Monica at 314-514-8509 extension 12 or email generalmailbox@clinicalresearchcenter.com to learn more

Clinical Study Identifier: TX228576

Study #3 : COPD Study enrolling for those just using rescue inhaler as needed or using once daily inhalers. Must not be currently taking inhaled steroids.

Brief description of study

This study is testing the safety and efficacy of a nebulized investigational medication for the treatment of COPD.

This study has either 6 visits over 28 weeks or 10 visits over 52 weeks. Study related pulmonary function testing, chest x ray, lab work, ECG’s and physical exams are included at no cost and compensation for participation may be provided.

Detailed Study Description

This study requires morning appointments. We are available Monday-Saturday. Compensation for participation is provided to those who qualify.

Please contact Monica at 314-514-8509 extension 12 or email generalmailbox@clinicalresearchcenter.com to learn more details.

Study #4 : COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.

Brief description of study

This investigational study is enrolling moderate to severe COPD subjects.

To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year, for your breathing.

Pulmonary function test will be performed and compensation will be provided for those who qualify.

Clinical Study Identifier: TX228636

Study #5 : Chronic Hives Research Study to evaluate investigational study medication by self injection at home

Brief description of study

The Clinical Research Center in West St. Louis County is conducting a research study of an investigational medication, given by self injection at home, to evaluate the safety and effectiveness in subjects who suffer with chronic hives. This study consists of 5 clinic visits and the study will be approximately 40 weeks long. Qualified patients will be omalizumab naive or incomplete/non responders. Hives must be present for the last 6 weeks depsite treatment with an H1 antihisstamine. 

Clinical Study Identifier: TX202119

Study #6 : Asthma Study for investigational injectable medication when added to patients already on standard of care inhaled medications.

Brief description of study

This study requires 14 visits over approximately 30 weeks. Visit are in mornings and are approximately every 2 weeks.

Detailed Study Description

Subjects must have physician diagnosed asthma and currently treating with medium to high dose inhaled medications and have at least one documented flare in breathing that required Prednisone within the last 18 months.

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call Monica at 314-514-8509 ext 12 for more details.

 

Contact CRC
By acknowledging or signing the agreement, the customer is authorizing The Clinical Research Center to periodically send text message updates about current or future studies that may be of interest. The Clinical Research Center will send occasional texts pertaining to studies that may be of interest to you or studies that you are enrolled in. You can opt-out at any time. Text and data rates may apply. Privacy Policy.